DeepMed Research

VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis

Completed

Conditions: Anaphylaxis

First Posted Date: 2009-03-25

Last Posted Date: 2014-04-14

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT00868842

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)

Not Applicable

Terminated

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: pioglitazone
Drug: Placebo

First Posted Date: 2009-03-24

Last Posted Date: 2016-06-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 51

Registration Number: NCT00868140

Locations: 🇻🇪
Hospital de Clinical Caracas, Caracas, Venezuela
🇺🇸
Virginia Commonwealth University General Clinical Research Center, Richmond, Virginia, United States

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

Phase 1

Terminated

Conditions: Lung Cancer

Interventions: Radiation: radiation therapy treatment planning/simulation
Procedure: implanted fiducial-based imaging

First Posted Date: 2009-03-05

Last Posted Date: 2013-12-20

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 6

Registration Number: NCT00856427

Locations: 🇺🇸
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Hepatocyte Transplantation in Liver Failure

Phase 1

Withdrawn

Conditions: Liver Failure

Interventions: Biological: Hepatocyte Transplantation

First Posted Date: 2008-12-09

Last Posted Date: 2014-08-05

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT00805610

Locations: 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States

Anakinra to Prevent Post-infarction Remodeling

Phase 3

Completed

Conditions: ST Segment Elevation Acute Myocardial Infarction

Interventions: Drug: Placebo
Drug: Anakinra

First Posted Date: 2008-11-13

Last Posted Date: 2017-11-30

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT00789724

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Islet After Kidney Transplant for Type 1 Diabetes

Phase 1

Withdrawn

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: etanercept

First Posted Date: 2008-11-05

Last Posted Date: 2014-09-16

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT00784966

Locations: 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States

An fMRI Study of SYN115 in Cocaine Dependent Subjects

Early Phase 1

Completed

Conditions: Cocaine Dependence

Interventions: Drug: PLACEBO
Drug: SYN115

First Posted Date: 2008-10-31

Last Posted Date: 2019-07-19

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 26

Registration Number: NCT00783276

Locations: 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States

A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias

Terminated

Conditions: Atrial Fibrillation

First Posted Date: 2008-09-05

Last Posted Date: 2013-05-27

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 106

Registration Number: NCT00747838

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Organizational Factors Influencing Practice Improvement in Community Based Care

Not Applicable

Completed

Conditions: Quality of Treatment Services

First Posted Date: 2008-09-04

Last Posted Date: 2012-02-22

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 910

Registration Number: NCT00746577

Locations: 🇺🇸
Richmond Behavioral Health Authority, Richmond, Virginia, United States

Caffeine and Cocaine

Phase 1

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Caffeine 150 MG
Drug: Amphetamine
Drug: Placebo
Drug: Caffeine 300 MG

First Posted Date: 2008-08-13

Last Posted Date: 2017-03-22

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 23

Registration Number: NCT00733993

Locations: 🇺🇸
The University of Texas Health Science Center, Houston, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy